Why Merck’s Cancer Drug Keytruda Can Be Key To Its Long Term Growth?
Keytruda’s Growth Can Help Merck By:
- Mitigating Sales Loss Due To Patent Expiration
- Tapping In Huge And Growing Oncology (And Immuno-Oncology) Market
Have more questions about Merck? See the links below.
- What’s Merck’s Revenue And Earnings Breakdown In Terms Of Therapeutic Areas?
- What Led To Nearly 15% Decline In Merck’s Revenues & EBITDA In The Last 5 Years?
- How Has Merck’s Revenue Composition Changed In The Last 5 Years?
Notes:
See More at Trefis | View Interactive Institutional Research (Powered by Trefis)